Gregers Emilie, Frederiksen Peter H, Udesen Nanna L J, Linde Louise, Banke Ann, Povlsen Amalie L, Larsen Jeppe P, Hassager Christian, Jensen Lisette O, Lassen Jens F, Schmidt Henrik, Ravn Hanne B, Heegaard Peter M H, Møller Jacob E
Department of Cardiology, The Heart Center, Copenhagen University Hospital Rigshospitalet, Blegdamsvej 9, 2100, Copenhagen O, Denmark.
Department of Cardiology, Odense University Hospital, Odense, Denmark.
Intensive Care Med Exp. 2024 Apr 22;12(1):39. doi: 10.1186/s40635-024-00625-8.
In selected cases of cardiogenic shock, veno-arterial extracorporeal membrane oxygenation (V-A ECMO) is combined with trans valvular micro axial flow pumps (ECMELLA). Observational studies indicate that ECMELLA may reduce mortality but exposing the patient to two advanced mechanical support devices may affect the early inflammatory response. We aimed to explore inflammatory biomarkers in a porcine cardiogenic shock model managed with V-A ECMO or ECMELLA.
Fourteen landrace pigs had acute myocardial infarction-induced cardiogenic shock with minimal arterial pulsatility by microsphere embolization and were afterwards managed 1:1 with either V-A ECMO or ECMELLA for 4 h. Serial blood samples were drawn hourly and analyzed for serum concentrations of interleukin 6 (IL-6), IL-8, tumor necrosis factor alpha, and serum amyloid A (SAA).
An increase in IL-6, IL-8, and SAA levels was observed during the experiment for both groups. At 2-4 h of support, IL-6 levels were higher in ECMELLA compared to V-A ECMO animals (difference: 1416 pg/ml, 1278 pg/ml, and 1030 pg/ml). SAA levels were higher in ECMELLA animals after 3 and 4 h of support (difference: 401 ng/ml and 524 ng/ml) and a significant treatment-by-time effect of ECMELLA on SAA was identified (p = 0.04). No statistical significant between-group differences were observed in carotid artery blood flow, urine output, and lactate levels.
Left ventricular unloading with Impella during V-A ECMO resulted in a more extensive inflammatory reaction despite similar end-organ perfusion.
在某些心源性休克病例中,静脉 - 动脉体外膜肺氧合(V - A ECMO)与经瓣膜微轴流泵(ECMELLA)联合使用。观察性研究表明,ECMELLA可能降低死亡率,但让患者同时使用两种先进的机械支持设备可能会影响早期炎症反应。我们旨在探讨在使用V - A ECMO或ECMELLA治疗的猪心源性休克模型中的炎症生物标志物。
14头长白猪通过微球栓塞诱导急性心肌梗死致心源性休克,动脉搏动微弱,随后按1:1比例分别用V - A ECMO或ECMELLA治疗4小时。每小时采集系列血样,分析血清白细胞介素6(IL - 6)、IL - 8、肿瘤坏死因子α和血清淀粉样蛋白A(SAA)的浓度。
两组实验期间IL - 6、IL - 8和SAA水平均升高。在支持治疗2 - 4小时时,与V - A ECMO组动物相比,ECMELLA组动物的IL - 6水平更高(差异分别为1416 pg/ml、1278 pg/ml和1030 pg/ml)。支持治疗3小时和4小时后,ECMELLA组动物的SAA水平更高(差异分别为401 ng/ml和524 ng/ml),且发现ECMELLA对SAA有显著的治疗时间交互效应(p = 0.04)。在颈动脉血流量、尿量和乳酸水平方面,未观察到组间统计学显著差异。
在V - A ECMO期间使用Impella进行左心室卸载,尽管终末器官灌注相似,但导致了更广泛的炎症反应。